Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
601607 On Other Exchanges
Symbol
Exchange
601607 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

shanghai pharmaceuticals-a (601607) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd. is engaged in the research and development, manufacture, distribution, and retail of pharmaceutical products in China and internationally. The company offers products ranging from chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices, etc. in various therapeutic areas, including cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, and antineoplastic. The company offers its products in various dosage forms, such as tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants, etc. It also distributes vaccines and high-end consumables; and provides hospital service solutions focusing on the extended supply chain services, clinical supportive services, logistics, and information technology services. In addition, the company operates a chain of drugstores, pharmacies, joint-venture drugstores, DTP drugstores, etc. It has a strategic alliance with Shanghai Institute of Materia Medica. Shanghai Pharmaceuticals Holding Co., Ltd. was formerly known as Shanghai No. 4 Pharmaceutical Co., Ltd. The company was incorporated in 1994 and is based in Shanghai, China.

39,891 Employees
Last Reported Date: 03/26/15
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

President and Executive Director
Total Annual Compensation: CNY575.0K
Chairman, Convener of Strategy Committee and ...
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Employee Supervisor
Total Annual Compensation: --
Chairman of the Supervisory Board
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

shanghai pharmaceuticals-a (601607) Key Developments

Shanghai Pharmaceuticals Holding Co., Ltd. Proposes Dividend for 2014

Shanghai Pharmaceuticals Holding Co., Ltd. announced that at the AGM to be held on May 29, 2015, the company will consider the profit distribution plan for 2014 as follows: it is proposed that, based on the total share capital of 2,688,910,538 shares as at December 31, 2014, a cash dividend of RMB 2.9 (tax inclusive) will be paid to all shareholders for every ten shares, totaling RMB 779,784,056.02, accounting for 30.09% of the consolidated profit attributable to owners of the company for 2014.

Shanghai Pharmaceuticals Holding Co., Ltd. Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

Shanghai Pharmaceuticals Holding Co., Ltd. reported audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported operating profit of RMB 3,063,297,000, profit before income tax of RMB 3,799,734,000, profit of RMB 2,992,017,000, profit attributable to owners of the company was RMB 2,591,131,000 or RMB 0.96 per share on revenue of RMB 92,398,894,000 against operating profit of RMB 2,749,134,000, profit before income tax of RMB 3,225,640,000, profit of RMB 2,597,272,000, profit attributable to owners of the company was RMB 2,213,579,000 or RMB 0.82 per share on revenue of RMB 78,222,817,000 for the same period a year ago. Net cash generated from operating activities was RMB 578,342,000 against RMB 314,674,000 for the same period a year ago. Purchases of property, plant and equipment and investment properties were RMB 1,165,804,000 against RMB 887,939,000 for the same period a year ago. Purchases of land use rights and intangible assets were RMB 125,689,000 against RMB 17,120,000 for the same period a year ago. Weighted average return on net assets was 9.67%.

Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, Mar 26, 2015

Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, Mar 26, 2015. Agenda: To approve the annual results of the company and its subsidiaries for the year ended 31 December 2014 and its publication; and to consider the payment of final dividend, if any.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY25.75 CNY +0.23

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY71.98 CNY -0.77
Jointown Pharmaceutical Group Co Ltd CNY24.98 CNY +0.01
Nanjing Pharmaceutical Co Ltd CNY13.46 CNY +0.28
Wanjia Group Holdings Ltd $0.48 HKD +0.01
View Industry Companies
 

Industry Analysis

601607

Industry Average

Valuation 601607 Industry Range
Price/Earnings 26.8x
Price/Sales 0.8x
Price/Book 2.5x
Price/Cash Flow 19.1x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI PHARMACEUTICALS-A, please visit www.pharm-sh.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.